7 June 2018

ScreenPoint Medical, a spin-off of Radboud university medical center, has raised 4.3 million euros from Siemens Healthineers and private investors. With these funds, the company can accelerate the market introduction of its learning computer program Transpara, which automatically interprets x-rays of breasts for possible tumors.

Radboud university medical center spin-off ScreenPoint Medical develops software applications that can detect breast cancer in early stages from x-rays of breasts (mammograms). 

Automatic interpretation
ScreenPoint’s product is called Transpara. It was developed based on artificial intelligence (AI) in combination with large image databases, and its aim is to facilitate and improve the interpreting of mammograms. The performance of the AI system can be compared to that of radiologists, and a recent study demonstrates that the detection performance of radiologists improves when they use Transpara. Use of the system could also help decrease radiologists’ workload.

Lack of radiologists
“Interpreting mammograms is one of the most challenging tasks in radiology”, says Nico Karssemeijer, CEO of ScreenPoint, “and a shortage of skilled radiologists exists in many regions around the world. While breast cancer incidence continues to rise, innovative artificial intelligence solutions are needed to ensure that the high quality of screening programs can be maintained.”

Strategic collaboration
The investment of Siemens Healthineers marks the beginning of a strategic collaboration between the companies in the field of breast imaging and provides ScreenPoint with the opportunity to keep developing in the area of precision medicine. “We are very excited about the opportunity to partner with Siemens Healthineers. This partnership will enable an accelerated market introduction of Transpara.” 


Nico Karssemeijer is member of theme Women's cancers.

Related news items


RIHS Open Day We are looking for enthusiastic researchers!

21 March 2019

On Sunday 6 October 2019 we will again open our doors and show our wonderful research to the general public.

read more

Bart Kiemeney will step down as director RIHS Invitation

21 March 2019

We would like to give you the opportunity to say goodbye to Bart as director of the Radboud Institute for Health Sciences on 28 March 16.00 hrs in the Tuinzaal.

read more

Protein supplementation improves lean body mass in physically active older adults

21 March 2019

In the Journal of Cachexia, Sarcopenia & Muscle, Dominique ten Haaf and colleagues described a randomized clinical trial to assess the effects of 12-weeks protein supplementation on body characteristics.

read more

eHealth Apps Replacing or Complementing Health Care Contacts

21 March 2019

In the Journal of Medical Internet Research, Pim Assendelft and colleagues from the University of Applied sciences Arnhem Nijmegen showed that still relatively little is known about the adverse effects of health apps when used to replace or complement contacts with doctors or nurses.

read more

Proudly presenting new theme leaders

20 March 2019

It is our pleasure to introduce the new leaders of the themes Mitochondrial diseases, Reconstructive and regenerative medicine and Vascular damage.

read more

Lieneke Steeghs about the PATH project: Predictive Analysis for Therapy

20 March 2019

Read here the article 'PATH makes predictive molecular diagnostics in cancer unambiguous', of Lieneke Steeghs, theme Tumors of the digestive tract, that was published on the website of ZonMw.

read more